These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 37171239)

  • 21. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
    Roeb E; Geier A
    Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database.
    Terai S; Buchanan-Hughes A; Ng A; Lee IH; Hasegawa K
    J Gastroenterol; 2021 Mar; 56(3):274-284. PubMed ID: 33496858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary care practitioners survey of non-alcoholic fatty liver disease.
    Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
    Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey.
    Campos C; Magwire M; Butler J; Hoovler A; Sabharwal A; Shah SJ
    BMC Prim Care; 2024 Aug; 25(1):288. PubMed ID: 39118004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy.
    Petta S; Ting J; Saragoni S; Degli Esposti L; Shreay S; Petroni ML; Marchesini G;
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):1014-1022. PubMed ID: 32423665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
    Younossi ZM; Alqahtani SA; Alswat K; Yilmaz Y; Keklikkiran C; Funuyet-Salas J; Romero-Gómez M; Fan JG; Zheng MH; El-Kassas M; Castera L; Liu CJ; Wai-Sun Wong V; Zelber-Sagi S; Allen AM; Lam B; Treeprasertsuk S; Hameed S; Takahashi H; Kawaguchi T; Schattenberg JM; Duseja A; Newsome PN; Francque S; Spearman CW; Castellanos Fernández MI; Burra P; Roberts SK; Chan WK; Arrese M; Silva M; Rinella M; Singal AK; Gordon S; Fuchs M; Alkhouri N; Cusi K; Loomba R; Ranagan J; Eskridge W; Kautz A; Ong JP; Kugelmas M; Eguchi Y; Diago M; Yu ML; Gerber L; Fornaresio L; Nader F; Henry L; Racila A; Golabi P; Stepanova M; Carrieri P; Lazarus JV;
    J Hepatol; 2024 Mar; 80(3):419-430. PubMed ID: 37984709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosis.
    Kuchay MS; Misra A
    Diabetes Metab Syndr; 2022 Mar; 16(3):102446. PubMed ID: 35259705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Hung CK; Bodenheimer HC
    Clin Liver Dis; 2018 Feb; 22(1):175-187. PubMed ID: 29128055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary care provider management of patients with obesity at an integrated health network: A survey of practices, views, and knowledge.
    Falvo AM; Hite Philp F; Eid GM
    Surg Obes Relat Dis; 2018 Aug; 14(8):1149-1154. PubMed ID: 29929858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
    Islam KB; Brandman D; Chu JN; Goldman ML; Fox RK
    Dig Dis Sci; 2023 Feb; 68(2):434-438. PubMed ID: 36178567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic Fatty Liver Disease and Diabetes Mellitus.
    Khneizer G; Rizvi S; Gawrieh S
    Adv Exp Med Biol; 2021; 1307():417-440. PubMed ID: 32424494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
    Cusi K; Isaacs S; Barb D; Basu R; Caprio S; Garvey WT; Kashyap S; Mechanick JI; Mouzaki M; Nadolsky K; Rinella ME; Vos MB; Younossi Z
    Endocr Pract; 2022 May; 28(5):528-562. PubMed ID: 35569886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Younossi ZM; Loomba R; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Chalasani NP; Anstee QM; Kowdley KV; George J; Goodman ZD; Lindor K
    Hepatology; 2018 Jul; 68(1):361-371. PubMed ID: 29222911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in NAFLD/NASH Management by Provider Specialty: Opportunities for Optimizing Multidisciplinary Care.
    Porayko MK; Articolo A; Cerenzia W; Coleman B; Patel D; Stacy S
    J Multidiscip Healthc; 2022; 15():1533-1545. PubMed ID: 35898947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.
    Lee-Kim V; Morkem R; Barber D; Flemming JA; Kehar M
    Paediatr Child Health; 2022 May; 27(2):93-98. PubMed ID: 35599680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approach to the Patient With Nonalcoholic Fatty Liver Disease.
    Belfort-DeAguiar R; Lomonaco R; Cusi K
    J Clin Endocrinol Metab; 2023 Jan; 108(2):483-495. PubMed ID: 36305273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
    Younossi ZM; Ong JP; Takahashi H; Yilmaz Y; Eguc Hi Y; El Kassas M; Buti M; Diago M; Zheng MH; Fan JG; Yu ML; Wai-Sun Wong V; Alswat K; Chan WK; Mendez-Sanchez N; Burra P; Bugianesi E; Duseja AK; George J; Papatheodoridis GV; Saeed H; Castera L; Arrese M; Kugelmas M; Romero-Gomez M; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1456-e1468. PubMed ID: 34229038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver.
    Godinez-Leiva E; Bril F
    Curr Hypertens Rev; 2021; 17(2):94-111. PubMed ID: 33302841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.